Causes of Mortality in Adults Treated for Hodgkin Lymphoma
Adults treated for Hodgkin lymphoma have an increased risk of death from heart disease, interstitial lung disease, infections, and adverse effects of therapy.
Adults treated for Hodgkin lymphoma have an increased risk of death from heart disease, interstitial lung disease, infections, and adverse effects of therapy.
Depending on the type and stage of lymphoma, physicians may choose to avoid having their patients undergo radiation therapy for fear of potential toxic effects in organs. How has modern radiation therapy evolved of late in terms of what it can do to organs at risk? A study published earlier this year in JAMA Network…
Among patients with early-stage, favorable Hodgkin lymphoma, treatment regimens with conventional chemotherapy may be effective in a subset of patients.
Exposure to doxorubicin during treatment for DLBCL was linked to a higher risk for cardiovascular diseases, highlighting the need for early cardiac surveillance.
View treatment regimens for Waldenstrom’s Macroglobulinemia/Lymphoplasmacytic Lymphoma, including combination therapies with bortezomib and more.
Get current treatment regimens for extranodal NK/T-cell lymphoma, which details options such as radiotherapy plus DeVic and SMILE + radiotherapy.
Access detailed treatment regimens for diffuse large B-cell lymphoma, such as R-CHOP with RT and radiotherapy.
View a treatment regimen chart for AIDS-related B-cell lymphoma, with detailed information based on condition (ie, Burkitt lyphoma, Castleman’s Disease).
Combined modality therapy for early-stage favorable HL yielded excellent outcomes and limited excess radiation doses to organs at risk.
Find comprehensive treatment regimens for Hodgkin lymphoma, including therapies such as ABVD + involved-field radiotherapy and more.